Senior Research Associate

Roles & Responsibilities:
• Conduct preclinical laboratory experiments supporting late-stage BMS asset programs
• Generate biomarker data to support patient selection strategies, dose & schedule optimization
• Design and execute experiments for combination strategies, resistance mechanism studies, and differentiation from standard of care
• Execute internal and collaborative translational projects, interfacing with Translational Medicine scientists and disease leaders
• Maintain accurate experimental records and present findings to internal teams
• Prepare non-clinical pharmacology study reports to support regulatory submissions
• Handle in vivo studies in autoimmune, solid tumor, or heme-oncology models as required

Qualification:
• Master’s degree (MSc, MS, MTech, or equivalent) in Life Sciences, Biotechnology, or related discipline

Experience:
• Relevant experience in immunology, oncology, or hemato-oncology research
• Industry experience in translational or preclinical research is preferred

Skills:
• Cell culture, primary cell isolation, transfection, single-cell cloning
• Gene editing workflows: siRNA, CRISPR, TALEN, HDR
• Gene expression analysis: qRT-PCR, RNA-Seq
• Epigenetics techniques: ChIP, methylation analysis
• Protein & immunoassays: ELISA, MSD, Luminex, CBA, TSA
• Flow cytometry and cell phenotyping
• Strong scientific writing, data analysis, and problem-solving skills
• Ability to work with animal models and human-derived samples; GCLP/CLIA exposure is a plus

Behavioral & Soft Skills:
• Self-driven, detail-oriented, and quality-focused researcher
• Comfortable in fast-paced, matrixed environments
• Excellent multitasking, troubleshooting, and independent working abilities
• Willingness to handle complex experiments and patient-derived samples

About the Organisation:
Syngene International Ltd. is a leading contract research organization providing integrated, discovery-to-development solutions for global pharmaceutical and biotech companies. Its Translational Medicine division focuses on biomarker-driven, preclinical research to support late-stage drug development. The company fosters a collaborative, innovative environment that enables researchers to contribute to cutting-edge projects in oncology, immunology, and translational medicine.